X
Search Filters
Format Format
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
abridged index medicus (2) 2
clinical trials (2) 2
humans (2) 2
index medicus (2) 2
medicine, general & internal (2) 2
ophthalmology (2) 2
research (2) 2
activating-factor acetylhydrolase (1) 1
aged (1) 1
anecdotes as topic (1) 1
angina (1) 1
arteriosclerosis (1) 1
assaigs clínics de medicaments (1) 1
atherosclerotic plaque (1) 1
benzaldehydes - administration & dosage (1) 1
benzaldehydes - adverse effects (1) 1
blindness (1) 1
cardiovascular agents (1) 1
cardiovascular disease (1) 1
cardiovascular diseases (1) 1
care and treatment (1) 1
cerebral infarction (1) 1
children (1) 1
clinical medicine (1) 1
clinical-outcomes (1) 1
coronary artery disease (1) 1
coronary artery disease - complications (1) 1
coronary artery disease - drug therapy (1) 1
coronary disease - drug therapy (1) 1
coronary disease - mortality (1) 1
coronary diseases (1) 1
coronary heart disease (1) 1
death (1) 1
diagnostic errors (1) 1
docosahexaenoic acid (1) 1
dosage and administration (1) 1
double-blind method (1) 1
drug testing (1) 1
drug therapy (1) 1
dystrophy (1) 1
female (1) 1
field fundus autofluorescence (1) 1
follow-up studies (1) 1
heart diseases (1) 1
infart de miocardi (1) 1
inhibitor (1) 1
ischemia (1) 1
kaplan-meier estimate (1) 1
klinisk medicin (1) 1
lipoprotein (1) 1
malalties cardiovasculars (1) 1
malalties coronàries (1) 1
male (1) 1
medical and health sciences (1) 1
medical treatment (1) 1
medicin och hälsovetenskap (1) 1
middle aged (1) 1
motivation (1) 1
myocardial infarction (1) 1
myocardial infarction - prevention & control (1) 1
myocardial ischemia (1) 1
online first (1) 1
oral administration (1) 1
original investigation (1) 1
oxidized ldl (1) 1
oximes - administration & dosage (1) 1
oximes - adverse effects (1) 1
perimetry (1) 1
phospholipase (1) 1
phospholipase a (1) 1
phospholipase a2 (1) 1
phospholipase a2 inhibitors - administration & dosage (1) 1
phospholipase a2 inhibitors - adverse effects (1) 1
physician-patient relations (1) 1
placebo effect (1) 1
plaques (1) 1
plasma levels (1) 1
prevention (1) 1
preventive medicine (1) 1
progression (1) 1
retina (1) 1
retinal degeneration (1) 1
retinitis (1) 1
retinitis pigmentosa (1) 1
rhodopsin (1) 1
rhodopsin mutations (1) 1
risk (1) 1
stroke - prevention & control (1) 1
therapy (1) 1
treatment failure (1) 1
trial (1) 1
valproic acid (1) 1
visual field (1) 1
more...
Language Language
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


by White, Harvey D and Held, Claes and Stewart, Ralph and Tarka, Elizabeth and Brown, Rebekkah and Davies, Richard Y and Budaj, Anzej and Harrington, Robert A and Steg, P. Gabriel and Ardissino, Diego and Armstrong, Paul W and Avezum, Alvaro and Aylward, Philip E and Bryce, Alfonso and Chen, Hong and Chen, Ming-Fong and Corbalan, Ramon and Dalby, Anthony J and Danchin, Nicolas and de Winter, Robbert J and Denchev, Stefan and Diaz, Rafael and Elisaf, Moses and Flather, Marcus D and Goudev, Assen R and Granger, Christopher B and Grinfeld, Liliana and Hochman, Judith S and Husted, Steen and Kim, Hyo-Soo and Koenig, Wolfgang and Linhart, Ales and Lonn, Eva and López-Sendón, José and Manolis, Athanasios J and Mohler, Emile R and Nicolau, José C and Pais, Prem and Parkhomenko, Alexander and Pedersen, Terje R and Pella, Daniel and Ramos-Corrales, Marco A and Ruda, Mikhail and Sereg, Mátyás and Siddique, Saulat and Sinnaeve, Peter and Smith, Peter and Sritara, Piyamitr and Swart, Henk P and Sy, Rody G and Teramoto, Tamio and Tse, Hung-Fat and Watson, David and Weaver, W. Douglas and Weiss, Robert and Viigimaa, Margus and Vinereanu, gos and Zhu, Junren and Cannon, Christopher P and Wallentin, Lars and Steg, Ph Gabriel and Bucan, Olga and Elfström, Charlotta and Hegg, Lisa and Jarosz, Marie and Krug-Gourley, Sue and Rudman, Jerry and Collins, Rory and Anderson, Jeffrey and DeMets, David and Ganz, Peter and Sandercock, Peter and Weber, Michael and Fisher, Marian and Buhr, Kevin and Diegel, Scott and Schultz, Melissa and Mahaffey, Kenneth W and Alexander, John H and Al-Khatib, Sana and Baron, Tomasz and Bergström, Olle and Bushnell, Cheryl and Christersson, Christina and Eggers, Kai and Fredlund, Bengt-Olov and Hagström, Emil and Hijazi, Ziad and Örndahl, Lovisa Holm and James, Stefan K and Jernberg, Tomas and Johnston, Nina and Lopez, Renato D and Mehta, Rajena H and Newby, Kristin L and Nordmark, Örjan and Oldgren, Jonas and Roe, Matthew T and Saldéen, Katarina and Stenborg, Anna and ... and The STABILITY Investigators and STABILITY Investigators and Medicinska fakulteten and Medicinska och farmaceutiska vetenskapsområdet and Kardiologi and Medicinska och farmaceutiska vetenskapsområdet, centrumbildningar mm and Uppsala universitet and Institutionen för medicinska vetenskaper and Uppsala kliniska forskningscentrum (UCR)
The New England Journal of Medicine, ISSN 0028-4793, 05/2014, Volume 370, Issue 18, pp. 1702 - 1711
Darapladib, an oral inhibitor of lipoprotein-associated phospholipase A2, was compared with placebo in 15,828 patients with stable coronary heart disease.... 
TRIAL | LIPOPROTEIN | MEDICINE, GENERAL & INTERNAL | THERAPY | ACTIVATING-FACTOR ACETYLHYDROLASE | OXIDIZED LDL | RISK | PHOSPHOLIPASE A | ATHEROSCLEROTIC PLAQUE | INHIBITOR | CLINICAL-OUTCOMES | Stroke - prevention & control | Double-Blind Method | Follow-Up Studies | Oximes - adverse effects | Phospholipase A2 Inhibitors - administration & dosage | Humans | Middle Aged | Kaplan-Meier Estimate | Oximes - administration & dosage | Male | Coronary Artery Disease - drug therapy | Coronary Disease - mortality | Phospholipase A2 Inhibitors - adverse effects | Benzaldehydes - adverse effects | Benzaldehydes - administration & dosage | Coronary Artery Disease - complications | Treatment Failure | Coronary Disease - drug therapy | Female | Aged | Myocardial Infarction - prevention & control | Prevention | Care and treatment | Ischemia | Dosage and administration | Research | Coronary heart disease | Cardiovascular agents | Myocardial infarction | Cerebral infarction | Phospholipase A2 | Clinical trials | Myocardial ischemia | Cardiovascular disease | Angina | Preventive medicine | Coronary artery disease | Phospholipase | Arteriosclerosis | Death | Plasma levels | Drug therapy | Heart diseases | Plaques | Index Medicus | Abridged Index Medicus | Malalties cardiovasculars | Infart de miocardi | Malalties coronàries | Assaigs clínics de medicaments | Cardiovascular diseases | Drug testing | Coronary diseases | Clinical Medicine | Medical and Health Sciences | Klinisk medicin | Medicin och hälsovetenskap
Journal Article
JAMA OPHTHALMOLOGY, ISSN 2168-6165, 08/2018, Volume 136, Issue 8, pp. 849 - 856
IMPORTANCE There are no approved drug treatments for autosomal dominant retinitis pigmentosa, a relentlessly progressive cause of adult and childhood... 
FIELD FUNDUS AUTOFLUORESCENCE | DYSTROPHY | PERIMETRY | DOCOSAHEXAENOIC ACID | OPHTHALMOLOGY | RHODOPSIN MUTATIONS | PROGRESSION | Online First | Original Investigation | Research
Journal Article
Annals of Internal Medicine, ISSN 0003-4819, 05/1998, Volume 128, Issue 9, pp. 785 - 786
Journal Article
No results were found for your search.

Cannot display more than 1000 results, please narrow the terms of your search.